Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.
1 Marsico Lung Institute, Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; and.
Jason R
JR
Mock
2 Division of Pulmonary and Critical Care Medicine.
Todd M
TM
Kolb
3 Division of Surgical Pathology.
Peter B
PB
Illei
4 Division of Thoracic Surgery, and.
Stephen C
SC
Yang
5 Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Howard M
HM
Lederman
2 Division of Pulmonary and Critical Care Medicine.
Christian A
CA
Merlo
D000015:Abnormalities, Multiple; D000328:Adult; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001980:Bronchi / Q000187:drug effects / Q000473:pathology*; D017074:Common Variable Immunodeficiency / Q000150:complications*; D005145:Face / Q000002:abnormalities*; D005260:Female; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D053306:Hyper-IgM Immunodeficiency Syndrome / Q000150:complications*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008221:Lymphoid Tissue / Q000187:drug effects / Q000473:pathology*; D000069283:Rituximab / Q000627:therapeutic use; D020775:Thoracic Surgery, Video-Assisted; D015837:Vestibular Diseases / Q000150:complications*
D000074322:Antineoplastic Agents, Immunological; D007166:Immunosuppressive Agents; D000069283:Rituximab; D001379:Azathioprine